Browsing: Trial

World-First Achievement:SUSMED’sBlockchain-Based Clinical Trial System Supports Successful Marketing Authorization for Pharmaceutical Product

In April 2026, Eastern District of Pennsylvania Senior Judge Michael M. Baylson and U.S. Magistrate Judge Caroline Goldner Cinquanto traveled to the University of Botswana at the invitation of the International Law Institute (ILI) to teach trial advocacy. Working with law clerks Caroline Kam, Madelaine Pisani, and Sarah Goodman, the judges designed a hands-on program…

Austrian industrialist Siegfried Wolf and former finance minister Hans Jörg Schelling went on trial near Vienna on Tuesday, charged by prosecutors with attempts to secure a tax waiver.

For the better part of a decade, the default advice handed to medtech founders planning a first-in-human (FIH) study fit in three words: go to Australia. The pitch was seductive and, for a while, mostly true. A notification-based regulatory pathway that could clear in weeks. A 43.5% refundable R&D tax offset. For a cash-constrained startup,…

The use of artificial intelligence in the courtroom is drawing fresh attention after plaintiffs in a multimillion-dollar lawsuit claimed an expert witness used ChatGPT to create more than 80% of his expert report.

Polestar and Clever are running the first complete V2X pilot in Denmark, with Polestar 4 acting as a home and grid power source

KUALA LUMPUR (Sept 2): An accountant claimed trial at the Georgetown Magistrates’ Court on Wednesday for allegedly assisting a company to evade RM2.5 million in income tax for the 2021 assessment year.

Neverness to Everness, the 2026 gacha game from developer Hotta Games that was mercilessly dragged online in April for its overabundance of AI-looking assets, is, for the third time this year, embroiled in another genAI controversy. It comesless than four months after the devs stated that the game“is built on human creativity” and that they…

Edward S. Kim, MD, MBA, explained how City of Hope leverages AI tools to help community oncologists match patients with multidisciplinary clinical trials.